Long-term ethanol exposure inhibits glucose transporter 4 expression via an AMPK-dependent pathway in adipocytes

Acta Pharmacologica Sinica

Volumn 31, Issue 3, 2010, Pages 329-340

  Feng, Li ^a,b   Song, Yong Feng ^a   Guan, Qing Bo ^a   Liu, Hong Jun ^a   Ban, Bo ^c   Dong, Hai Xin ^c   Hou, Xiao Lei ^a   Lee, Kok Onn ^d   Gao, Ling ^a   Zhao, Jia Jun ^a  

^a Provincial Hospital   (China)

^b THE FIRST AFFILIATED HOSPITAL OF SHANDONG FIRST MEDICAL UNIVERSITY   (China)

^c Affiliated Hospital of Jining Medical University   (China)

^d NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Adipose tissue; AMP activated protein kinase; Ethanol; Glucose transporter 4; Myocyte enhancer factor 2

Indexed keywords

5 AMINO 4 IMIDAZOLECARBOXAMIDE RIBOSIDE; ALCOHOL; GLUCOSE; GLUCOSE TRANSPORTER 4; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; MYOCYTE ENHANCER FACTOR 2; SODIUM CHLORIDE;

ADIPOCYTE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL ISOLATION; CONTROLLED STUDY; DRUG INHIBITION; ENZYME ACTIVATION; ENZYME INHIBITION; EPIDIDYMIS FAT; GLUCOSE TOLERANCE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INSULIN SENSITIVITY; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ADIPOCYTES; AMP-ACTIVATED PROTEIN KINASES; ANIMALS; CELLS, CULTURED; ETHANOL; GENE EXPRESSION REGULATION; GLUCOSE INTOLERANCE; GLUCOSE TRANSPORTER TYPE 4; HUMANS; MALE; MYOGENIC REGULATORY FACTORS; RATS; TIME FACTORS;

EID: 77749233737     PISSN: 16714083     EISSN: 17457254     Source Type: Journal    
DOI: 10.1038/aps.2010.11     Document Type: Article

References (62)

1. Minokoshi Y, Kahn CR, Kahn BB. Tissue-specific ablation of the GLUT4 glucose transporter or the insulin receptor challenges assumptions about insulin action and glucose homeostasis. J Bio Chem 2003; 278: 33609-12
2. Shepherd PR, Gnudi L, Tozzo E, Yang H, Leach F, Kahn BB. Adipose cell hyperplasia and enhanced glucose disposal in transgenic mice overexpressing GLUT4 selectively in adipose tissue. J Biol Chem 1993; 268: 22243-6
3. Chen L, Nyomba BL. Effects of prenatal alcohol exposure on glucose tolerance in the rat offspring. Metabolism 2003; 52: 454-62
4. Wilkes JJ, Nagy LE. Chronic ethanol feeding impairs glucose tolerance but does not produce skeletal muscle insulin resistance in rat epitrochlearis muscle. Alcohol Clin Exp Res 1996; 20: 1016-22
5. Poirier LA, Rachdaoui N, Nagy LE. GLUT4 vesicle trafficking in rat adipocytes after ethanol feeding: regulation by heterotrimeric G-proteins. Biochem J 2001; 354: 323-30
6. Feng L, Gao L, Guan Q, Hou X, Wan Q, Wang X, et al. Long-term moderate ethanol consumption restores insulin sensitivity in high-fat-fed rats by increasing GLUT4 in the adipose tissue by AMPK activation. J Endocrinol 2008; 199: 95-104
7. Qu W, Hao L, Chen Y, Zhou S. Effect of chronic ethanol intake on nsulin receptor, insulin receptor subsrate-1 and phosphoinositide 3-kinase mRNA expression in skeletal muscle of rats. Wei Sheng Yan Jiu 2007; 36: 172-5
8. Zhou SL, Hao LP, Chen YY, Qu W. Influence of chronic ethanol intake on insulin sensitivity and IR, IRS-1, IRS-2 mRNA expression of liver in male rats. Wei Sheng Yan Jiu 2006; 35: 294-6
9. Wan Q, Liu Y, Guan Q, Gao L, Lee KO, Zhao J. Ethanol feeding impairs nsulin-stimulated glucose uptake in isolated rat skeletal muscle: role of Gs alpha and cAMP Alcohol Clin Exp Res 2005; 29: 1450-6
10. Sebastian BM, Nagy LE. Decreased insulin-dependent glucose transport by chronic ethanol feeding is associated with dysregulation of the Cbl/TC10 pathway in rat adipocytes. Am J Physiol Endocrino Metab 2005; 289: E1077-1084
11. García-Villafranca J, Guillén A, Castro J. Ethanol consumption impairs regulation of fatty acid metabolism by decreasing the activity of AMP-activated protein kinase in rat liver. Biochimie 2008; 90: 460-6
12. You M, Matsumoto M, Pacold CM, Cho WK, Crabb DW. The role of AMP-activated protein kinase in the action of ethanol in the liver Gastroenterology 2004; 127: 1798-808
13. Chakraborty G, Saito M, Mao RF, Wang R, Vadasz C, Saito M Lithium blocks ethanol-induced modulation of protein kinases in the developing brain. Biochem Biophys Res Commun 2008; 367: 597-602
14. Saito M, Chakraborty G, Mao RF, Wang R, Cooper TB, Vadasz C, et al. Ethanol alters lipid profiles and phosphorylation status of AMP-activated protein kinase in the neonatal mouse brain. J Neurochem 2007; 103: 1208-18
15. Hong-Brown LQ, Brown CR, Huber DS, Lang CH. Alcohol regulates eukaryotic elongation factor 2 phosphorylation via an AMP-activated protein kinase-dependent mechanism in C2C12 skeletal myocytes. J Biol Chem 2007; 282: 3702-12
16. Carling D. The AMP-activated protein kinase cascade - A unifying system for energy control. Trends Biochem 2004; 29: 18-24
17. Kemp BE, M itch elhi ll KI, Stapleton D, Michell BJ, Chen ZP, Witters LA. Dealing with energy demand: the AMP-activated protein kinase Trends Biochem Sci 1999; 24: 22-5
18. Stapleton D, Mitchelhill KI, Gao G, Widmer J, Michell BJ, Teh T, et al Mammalian AMP-activated protein kinase subfamily. J Biol Chem 1996; 271: 611-4
19. Hardie DG, Carling D, Carlson M. The AMP-activated/SNF1 protein kinase subfamily: metabolic sensors of the eukaryotic cell. Annu Rev Biochem 1998; 67: 821-55
20. Jessen N, Pold R, Buhl ES, Jensen LS, Schmitz O, Lund S. Effects of AICAR and exercise on insulin-stimulated glucose uptake, signaling and GLUT-4 content in rat muscles. J Appl Physiol 2003, 94: 1373-9
21. Kurth-Kraczek EJ, Hirshman MF, Goodyear LJ, Winder WW. 5′AMP-activated protein kinase activation causes GLUT4 translocation in skeletal muscle. Diabetes 1999; 48: 1667-71
22. Sakoda H, Ogihara T, Anai M, Fujishiro M, Ono H, Onishi Y, et al Activation of AMPK is essential for AICAR-induced glucose uptake by skeletal muscle but not adipocytes. Am J Physiol Endocrinol Metab 2002; 282: E1239-E1244
23. Salt IP, Connell JM, Gould GW. 5-aminoimidazole-4-carboxamide ribonucleoside (AICAR) inhibits insulin-stimulated glucose transport in 3T3-L1 adipocytes. Diabetes 2000; 49: 1649-56
24. Yamaguchi S, Katahira H, Ozawa S, Nakamichi Y, Tanaka T, Shimoyama T, et al. Activators of AMP-activated protein kinase enhance GLUT4 translocation and its glucose transport activity in 3T3-L1 adipocytes. Am J Physiol Endocrinol Metab 2005; 289 E643-E649
25. Al-Khalili L, Chibalin AV, Yu M, Sjodin B, Nylen C, Zierath JR, et al MEF2 activation in differentiated primary human skeletal muscle cultures requires coordinated involvement of parallel pathways. Am J Physiol Cell Physiol 2004; 286: C1410-C1416
26. Mora S, Pessin JE. The MEF2A isoform is required for striated muscle-specific expression of the insulin-responsive GLUT4 glucose transporter. J Biol Chem 2000; 275: 16323-8
27. Zheng D, MacLean PS, Pohnert SC, Knight JB, Olson AL, Winder WW et al. Regulation of muscle GLUT-4 transcription by AMP-activated protein kinase. J Appl Physiol 2001; 91: 1073-83
28. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cel function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-9
29. Tanti JF, Cormont M, Gremeaux T, Le Marchand-Brustel Y. Assays of glucose entry, glucose transporter amount, and translocation. In Ailhaud G, Ed. Methods in molecular biology. Vol 155: Adipose Tissue Protocols. Totowa (NJ): Humana Press; 2001. p 157-65
30. Wu X, Motoshima H, Mahadev K, Stalker TJ, Scalia R, Goldstein BJ. Involvement of AMP-activated protein kinase in glucose uptake stimulated by the globular domain of adiponectin in primary rat adipocytes. Diabetes 2003; 52: 1355-63
31. Li H, Kim KH. Effects of ethanol on embryonic and neonatal rat testes n organ cultures. J Androl 2003; 24: 653-60
32. Szabo G, Puppolo M, Verma B, Catalano D. Regulatory potential of ethanol and retinoic acid on human monocyte functions. Alcohol Clin Exp Res 1994; 18: 548-54
33. He L, Marecki JC, Serrero G, Simmen FA, Ronis MJ, Badger TM. Dose-dependent effects of alcohol on insulin signaling: partial explanation for biphasic alcohol impact on human health. Mol Endocrinol 2007 21: 2541-50
34. Bierhaus A, Schiekofer S, Schwaninger M, Andrassy M, Humpert PM, Chen J, et al. Diabetes-associated sustained activation of the transcription factor nuclear factor-kappaB. Diabetes 2001; 50 2792-808
35. Ezaki O. Regulatory elements in the insulin-responsive glucose transporter (GLUT4) gene. Biochem Biophys Res Commun 1997; 241: 1-6.
36. Liu ML, Olson AL, Edgington NP, Moye-Rowley WS, Pessin JE. Myocyte enhancer factor 2 (MEF2) binding site is essential for C2C12 myotube-specific expression of the rat GLUT4/muscle-adipose facilitative glucose transporter gene. J Biol Chem 1994; 269: 28514-21
37. Bell RA, Mayer-Davis EJ, Martin MA, D'Agostino RB Jr, Haffner SM Associations between alcohol consumption and insulin sensitivity and cardiovascular disease risk factors: the Insulin Resistance and Atherosclerosis Study. Diabetes Care 2000; 23: 1630-6
38. Cooper DE, Goff DC Jr, Bell RA, Zaccaro D, Mayer-Davis EJ, Karter AJ. Is insulin sensitivity a causal intermediate in the relationship between alcohol consumption and carotid atherosclerosis: the insulin resistance and atherosclerosis study. Diabetes Care 2002; 25 1425-31
39. Dixon JB, Dixon ME, O'Brien PE. Alcohol consumption in the severely obese: relationship with the metabolic syndrome. Obes Res 2002 10: 245-52
40. Goude D, Fagerberg B, Hulthe J, AIR Study Group. Alcohol consumption, the metabolic syndrome and insulin resistance in 58-year-old clinically healthy men (AIR study). Clin Sci 2002; 102: 345-52
41. Zilkens RR, Burke V, Watts G, Beilin LJ, Puddey IB. The effect of alcohol intake on insulin sensitivity in men: a randomized controlled trial. Diabetes Care 2003; 26: 608-12
42. Black BL, Olson EN. Transcriptional control of muscle development by myocyte enhancer factor-2 (MEF2) proteins. Annu Rev Cell Dev Bio 1998; 14: 167-96
43. Yu YT. Distinct domains of myocyte enhancer binding factor-2A determining nuclear localization and cell type-specific transcriptiona activity. J Biol Chem 1996; 271: 24675-83
44. Borghi S, Molinari S, Razzini G, Parise F, Battini R, Ferrari S. The nuclear localization domain of the MEF2 family of transcription factors shows member-specific features and mediates the nuclear import of histone deacetylase 4. J Cell Sci 2001; 114: 4477-83
45. Knight JB, Eyster CA, Griesel BA, Olson AL. Regulation of the human GLUT4 gene promoter: interaction between a transcriptional activator and myocyte enhancer factor 2A. Proc Natl Acad Sci USA 2003; 100: 14725-30
46. Mora S, Yang C, Ryder JW, Boeglin D, Pessin JE. The MEF2A and MEF2D isoforms are differentially regulated in muscle and adipose tissue during states of insulin defciency. Endocrinology 2001; 142: 1999-2004
47. Giri S, Rattan R, Haq E, Khan M, Yasmin R, Won JS, et al. AICAR nhibits adipocyte differentiation in 3T3L1 and restores metabolic alterations in diet-induced obesity mice model. Nutr Metab 2006; 3: 31
48. Holmes BF, Sparling DP, Olson AL, Winder WW, Dohm GL. Regulation of muscle GLUT4 enhancer factor and myocyte enhancer factor 2 by AMP-activated protein kinase. Am J Physiol Endocrinol Metab 2005 289: E1071-E1076
49. Buhl ES, Jessen N, Schmitz O, Pedersen SB, Pedersen O, Holman GD, et al. Chronic treatment with 5-aminoimidazole-4-carboxamide-1-beta-D- ribofuranoside increases insulin-stimulated glucose uptake and GLUT4 translocation in rat skeletal muscles in a fiber type-specific manner. Diabetes 2001; 50: 12-7
50. Koistinen HA, Galuska D, Chibalin AV, Yang J, Zierath JR, Holman GD et al. 5-amino-imidazole carboxamide riboside increases glucose transport and cell-surface GLUT4 content in skeletal muscle from subjects with type 2 diabetes. Diabetes 2003, 52: 1066-72
51. Gaidhu MP, Fediuc S, Ceddia RB. 5-Aminoimidazole-4-carboxamide-1-beta- D-ribofuranoside - induced AMP-activated protein kinase phosphorylation inhibits basal and insulin-stimulated glucose uptake lipid synthesis, and fatty acid oxidation in isolated rat adipocytes. J Biol Chem 2006; 281: 25956-64
52. Zakhari S, Li TK. Determinants of alcohol use and abuse: Impact of quantity and frequency patterns on liver disease. Hepatology 2007 46: 2032-9
53. Fan AZ, Russell M, Naimi T, Li Y, Liao Y, Jiles R, et al. Patterns of alcohol consumption and the metabolic syndrome. J Clin Endocrino Metab 2008; 93: 3833-8
54. Sparagna GC, Jones CE, Hickson-Bick DL. Attenuation of fatty acid-nduced apoptosis by low-dose alcohol in neonatal rat cardiomyocytes Am J Physiol Heart Circ Physiol 2004; 287: H2209-H2215
55. Nanji AA, Mendenhall CL, French SW. Beef fat prevents alcoholic liver disease in the rat. Alcohol Clin Exp Res 1989; 13: 15-9
56. Nanji AA, Sadrzadeh SM, Yang EK, Fogt F, Meydani M, Dannenberg AJ. Dietary saturated fatty acids: a novel treatment for alcoholic liver disease. Gastroenterology 1995; 109: 547-54
57. Mezey E. Dietary fat and alcoholic liver disease. Hepatology 1998 28: 901-5
58. Satoh S, Uetake S, Ohata M, Nakajima H, Yamauchi M. Effect of type of dietary fat and ethanol on hepatic leukotriene level in experimenta alcoholic liver disease. Nihon Nihon Arukoru Yakubutsu Igakka Zasshi 2003; 38: 350-63
59. Ronis MJ, Korourian S, Zipperman M, Hakkak R, Badger TM. Dietary saturated fat reduces alcoholic hepatotoxicity in rats by altering fatty acid metabolism and membrane composition. J Nutr 2004; 134 904-12
60. You M, Considine RV, Leone TC, Kelly DP, Crabb DW. Role of adiponectin in the protective action of dietary saturated fat against alcoholic fatty liver in mice. Hepatology 2005; 42: 568-77
61. Nanji AA, Yang EK, Fogt F, Sadrzadeh SM, Dannenberg AJ. Medium chain triglycerides and vitamin E reduce the severity of established experimental alcoholic liver disease. J Pharmacol Exp Ther 1996 277: 1694-700
62. Nanji AA, Jokelainen K, Tipoe GL, Rahemtulla A, Dannenberg AJ Dietary saturated fatty acids reverse inflammatory and fibrotic changes in rat liver despite continued ethanol administration. J Pharmacol Exp Ther 2001; 299: 638-44